Court Decisions Healthcare Manufacturing 
FDA Law Blog
NOVEMBER 30, 2022
Last month the United States Court of Appeals for the Second Circuit affirmed the district court’s decision to dismiss a False Claims Act (FCA) ( 21 U.S.C 3729) quit tam suit, alleging that Grifols USA, Grifols Biologicals, Grifols, S.A.,
FDA Law Blog
JUNE 15, 2022
The hospitals argued that the profits helped them offset the considerable costs of providing healthcare to the uninsured and underinsured in low-income and rural communities, something that Congress was well aware of and intended when it passed the Medicare Prescription Drug, Improvement, and Modernization Act in 2003.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
JURIST
NOVEMBER 1, 2021
A Second Circuit decision vacated two lower court rulings which allowed healthcare workers to claim religious exemptions to New York’s COVID-19 vaccine mandate. The decision also vacated an injunction from the Northern District of New York and a prior Second Circuit ruling on an Eastern District of New York case.
FDA Law Blog
AUGUST 21, 2023
Thus, Defendants argued that FDA already required the warning for pregnancy, rendering the decision to use it during pregnancy to a healthcare professional, and that FDA had considered the risks of in utero exposure and rejected the addition of those risks to the labeling. billion in damages were brought between 1980 and 1986.
JURIST
MARCH 26, 2024
The court heard arguments from the Food and Drug Administration (FDA), Danco (a drug manufacturer that only makes mifepristone) and the Alliance for Hippocratic Medicine (AHM). The questions focused on whether the AHM had standing to bring the case to court. Pro-choice pro testers held signs that said “Abortion is our right.
Above The Law
MARCH 7, 2025
Justice Barrett : 929 words Justice Barretts questioning primarily sought to clarify legal nuances surrounding the conscience protections for healthcare workers, the standing of associations in legal challenges, and the implications of regulations related to abortion and its associated medical procedures. Reynolds Vapor Co.
The Estrin Report
MARCH 16, 2025
Some of the most significant areas include: Regulatory Changes The deregulatory agenda in healthcare, finance, and environmental law has introduced significant uncertainty. Furthermore, recent Supreme Court decisions curbing the power of regulatory agencies set the stage for an additional litigation surge.
Expert insights. Personalized for you.
72 
Let's personalize your content